CL
Colgate-Palmolive Company
$90.13
-$0.48(-0.53%)
64
Overall
75
Value
58
Tech
60
Quality
Market Cap
$63.04B
Volume
2.85M
52W Range
$74.55 - $99.33
Target Price
$95.16
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $15.2B | $15.5B | $15.5B | $15.7B | $16.5B | $17.4B | $18.0B | $19.5B | $20.1B | $20.4B | ||
| Total Revenue | $15.2B | $15.5B | $15.5B | $15.7B | $16.5B | $17.4B | $18.0B | $19.5B | $20.1B | $20.4B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $1.1B | $6.2B | $6.3B | $6.4B | $6.5B | $7.0B | $7.7B | $8.1B | $7.9B | $8.1B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $9.1B | $9.3B | $9.2B | $9.3B | $10.0B | $10.4B | $10.2B | $11.3B | $12.2B | $12.3B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $11.4B | $5.6B | $11.8B | $5.8B | $12.6B | $13.5B | $6.6B | $7.3B | $7.9B | $8.0B | ||
| Research & Development | $289.0M | $285.0M | $277.0M | $281.0M | $290.0M | $307.0M | $320.0M | $343.0M | $355.0M | -- | ||
| Research Expense | $289.0M | $285.0M | $277.0M | $281.0M | $290.0M | $307.0M | -- | -- | -- | -- | ||
| Selling, General & Administrative | $5.2B | $5.4B | $5.4B | $5.6B | $12.5B | $6.4B | $6.6B | $7.2B | $7.7B | $7.9B | ||
| Selling & Marketing Expenses | $1.4B | $1.6B | $1.6B | $1.7B | $1.9B | $2.0B | $2.0B | $2.4B | $2.7B | -- | ||
| General & Administrative Expenses | $5.2B | $5.4B | $5.4B | $5.6B | $12.5B | $6.4B | $6.6B | $7.2B | $7.7B | $7.9B | ||
| Promotion & Advertising | $1.4B | $1.6B | $1.6B | $1.7B | $1.9B | $2.0B | -- | -- | -- | -- | ||
| Salaries & Wages | $-40.0M | $-42.0M | $-25.0M | $-20.0M | $-20.0M | $-25.0M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $443.0M | $475.0M | $511.0M | $519.0M | $539.0M | $7.0B | $545.0M | $567.0M | $605.0M | -- | ||
| Depreciation & Amortization | $443.0M | $102.0M | $511.0M | $519.0M | $539.0M | $7.0B | -- | -- | -- | -- | ||
| Amortization | $2.1B | $2.2B | $2.5B | $3.5B | $3.8B | $7.0B | $3.4B | $3.4B | $75.0M | $78.0M | ||
| Other Operating Expenses | $37.0M | $173.0M | $148.0M | $196.0M | $113.0M | $65.0M | $69.0M | $191.0M | $164.0M | $123.0M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $3.8B | $3.7B | $3.7B | $3.6B | $3.9B | $3.3B | $2.9B | $4.0B | $4.3B | $3.3B | ||
| EBITDA | $4.3B | $4.1B | $4.2B | $4.0B | $4.4B | $3.8B | $3.4B | $4.2B | $4.9B | $4.0B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $155.0M | $156.0M | $195.0M | $193.0M | $183.0M | $117.0M | $167.0M | $287.0M | $292.0M | $267.0M | ||
| Intinc | $50.0M | $51.0M | $50.0M | $47.0M | $19.0M | $17.0M | $14.0M | $55.0M | $67.0M | $75.0M | ||
| Net Non-Operating Interest Income/Expense | $-105.0M | $-105.0M | $-145.0M | $-146.0M | $-165.0M | $-103.0M | $153.0M | $-232.0M | $-225.0M | $-192.0M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $-18.0M | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $-107.0M | $118.0M | $87.0M | $108.0M | $74.0M | $70.0M | $-804.0M | $360.0M | $87.0M | $55.0M | ||
| Other Special Charges | -- | $-118.0M | $-87.0M | $-108.0M | $-74.0M | $-70.0M | $-80.0M | $-360.0M | $-87.0M | $-55.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $105.0M | $152.0M | $88.0M | $57.0M | $-13.0M | -- | $90.0M | $24.0M | $59.0M | $7.0M | ||
| Special Income Charges | $-105.0M | $-152.0M | $-88.0M | $-57.0M | $13.0M | $-571.0M | $-721.0M | $-291.0M | $-59.0M | $-919.0M | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $571.0M | $721.0M | -- | -- | $919.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $3.9B | $3.6B | $3.7B | $3.5B | $3.8B | $3.2B | $2.8B | $3.7B | $4.2B | $3.3B | ||
| Pre-Tax Income | $3.7B | $3.5B | $3.5B | $3.3B | $3.6B | $3.1B | $2.7B | $3.4B | $4.0B | $3.1B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $1.2B | $1.3B | $906.0M | $7.1B | $787.0M | $749.0M | $693.0M | $937.0M | $907.0M | $798.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $2.4B | $2.0B | $2.4B | $2.4B | $2.7B | $2.2B | $1.8B | $2.3B | $2.9B | $2.1B | ||
| Net Income (Continuing Operations) | $2.4B | $2.0B | $2.4B | $2.4B | $2.7B | $2.2B | $2.0B | $2.5B | $3.0B | $2.3B | ||
| Net Income (Discontinued Operations) | $2.4B | $2.0B | $2.4B | $2.4B | $2.7B | $2.2B | $1.8B | $2.3B | $2.9B | $2.1B | ||
| Net Income (Common Stockholders) | $2.5B | $2.1B | $2.5B | $2.5B | $2.7B | $2.2B | $1.8B | $2.3B | $2.9B | $2.1B | ||
| Normalized Income | $8.5B | $2.4B | $9.1B | $2.7B | $2.9B | -- | -- | -- | -- | $4.0B | ||
| TOTALS | ||||||||||||
| Total Expenses | $12.5B | $12.0B | $18.2B | $12.1B | $19.0B | $20.6B | $14.3B | $15.5B | $15.8B | $16.2B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $891.8M | $881.8M | $870.6M | $859.1M | $856.8M | $845.0M | $836.4M | $827.3M | $209.3M | $807.6M | ||
| Average Shares Outstanding (Diluted) | $898.4M | $887.8M | $873.0M | $861.1M | $859.3M | $848.3M | $838.8M | $830.3M | $210.5M | $810.6M | ||
| Shares Outstanding | $882.9M | $875.3M | $861.7M | $855.0M | $848.6M | $840.5M | $830.4M | $823.2M | $811.5M | $801.5M | ||
| Basic EPS | $2.74 | $2.3 | $2.76 | $2.76 | $3.15 | $2.56 | $2.13 | $2.78 | $3.53 | $2.64 | ||
| Basic EPS (Continuing Operations) | -- | -- | $2.76 | $2.76 | $3.15 | $2.56 | $2.13 | $2.78 | $3.53 | $2.64 | ||
| Diluted EPS | $2.72 | $2.28 | $2.75 | $2.75 | $3.14 | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $2.75 | $2.75 | $3.14 | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 | ||
| Dividend Per Share | $1.55 | $1.59 | $1.66 | $1.71 | $1.75 | $1.79 | $1.86 | $1.91 | $2.48 | $2.08 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | $6.1B | -- | $6.3B | $20.0M | -- | -- | -- | -- | -- | -- | ||
| Depletion | -- | $102.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $10.0M | $11.0M | $10.0M | $9.0M | $12.0M | $12.0M | $12.0M | $17.0M | $22.0M | $20.0M | ||
| Earnings From Equity Interest Net Of Tax | $10.0M | $11.0M | $10.0M | $9.0M | $12.0M | $12.0M | $12.0M | $17.0M | $22.0M | $20.0M | ||
| Gain On Sale Of P P E | $97.0M | -- | -- | -- | -- | -- | $47.0M | -- | -- | -- | ||
| Insurance And Claims | $99.0M | -- | -- | -- | $6.5B | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $-6.0M | $-3.0M | $-2.0M | $-1.0M | $-1.0M | $-3.0M | $-5.0M | $-12.0M | -- | -- | ||
| Minority Interests | $-145.0M | $-150.0M | $-158.0M | $-160.0M | $-165.0M | $-172.0M | $-182.0M | $-155.0M | $-160.0M | $-129.0M | ||
| Non Recurring Operation Expense | -- | -- | $6.3B | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $5.2B | $5.4B | $5.4B | $5.6B | $12.5B | $6.4B | $6.6B | $7.2B | $7.7B | $7.9B | ||
| Rent And Landing Fees | $204.0M | $211.0M | $213.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $5.2B | $5.5B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Write Down | -- | -- | -- | $6.4B | -- | -- | -- | -- | -- | -- | ||
| Restruct | $105.0M | $152.0M | $88.0M | $57.0M | $-13.0M | -- | $90.0M | $24.0M | $59.0M | $7.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CL | $90.13 | -0.5% | 2.85M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Colgate-Palmolive Company Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW